Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein
Sivakumar Jeyarajan*, Jennifer Xavier*, N Madhusudhana Rao, Vijaya GopalCentre for Cellular and Molecular Biology, Council for Scientific and Industrial Research, Hyderabad, Andhra Pradesh, India; *These authors contributed equally to this workAbstract: A major rate-limiting step in nonviral gene de...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d10649d76b1944679790f21da2675c95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d10649d76b1944679790f21da2675c95 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d10649d76b1944679790f21da2675c952021-12-02T05:17:40ZPlasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein1176-91141178-2013https://doaj.org/article/d10649d76b1944679790f21da2675c952010-09-01T00:00:00Zhttp://www.dovepress.com/plasmid-dna-delivery-into-mda-mb-453-cells-mediated-by-recombinant-her-a5333https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Sivakumar Jeyarajan*, Jennifer Xavier*, N Madhusudhana Rao, Vijaya GopalCentre for Cellular and Molecular Biology, Council for Scientific and Industrial Research, Hyderabad, Andhra Pradesh, India; *These authors contributed equally to this workAbstract: A major rate-limiting step in nonviral gene delivery is the entry of nucleic acids across various membrane barriers and eventually into the nucleus where it must be transcribed. Cell-penetrating peptides and proteins are employed to generate formulations that overcome these challenges to facilitate DNA delivery into cells efficiently. However, these are limited by their inability to deliver nucleic acids selectively due to lack of specificity because they deliver to both cancer and normal cells. In this study, through modular design, we generated a recombinant fusion protein designated as Her-nuclear localization sequence (Her-NLS), where heregulin-a (Her), a targeting moiety, was cloned in frame with cationic NLS peptide to obtain a cell-specific targeting biomolecule for nucleic acid delivery. The heregulin-a1 isoform possesses the epidermal growth factor-like domain and binds to HER2/3 heterodimers which are overexpressed in certain breast cancers. Purified recombinant Her-NLS fusion protein binds plasmid DNA and specifically transfects MDA-MB-453 cells overexpressing the epidermal growth factor receptors HER2/3 in vitro. The approach described would also permit replacement of heregulin ligand with other targeting moieties that would be suited to cell-specific nucleic acid delivery mediated via receptor-ligand interactions.Keywords: cell targeting, nucleic acid delivery, nuclear localization sequences, heregulin, transfection, HER2 receptors Sivakumar JeyarajanJennifer XavierN Madhusudhana Raoet alDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2010, Iss default, Pp 725-733 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Sivakumar Jeyarajan Jennifer Xavier N Madhusudhana Rao et al Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
description |
Sivakumar Jeyarajan*, Jennifer Xavier*, N Madhusudhana Rao, Vijaya GopalCentre for Cellular and Molecular Biology, Council for Scientific and Industrial Research, Hyderabad, Andhra Pradesh, India; *These authors contributed equally to this workAbstract: A major rate-limiting step in nonviral gene delivery is the entry of nucleic acids across various membrane barriers and eventually into the nucleus where it must be transcribed. Cell-penetrating peptides and proteins are employed to generate formulations that overcome these challenges to facilitate DNA delivery into cells efficiently. However, these are limited by their inability to deliver nucleic acids selectively due to lack of specificity because they deliver to both cancer and normal cells. In this study, through modular design, we generated a recombinant fusion protein designated as Her-nuclear localization sequence (Her-NLS), where heregulin-a (Her), a targeting moiety, was cloned in frame with cationic NLS peptide to obtain a cell-specific targeting biomolecule for nucleic acid delivery. The heregulin-a1 isoform possesses the epidermal growth factor-like domain and binds to HER2/3 heterodimers which are overexpressed in certain breast cancers. Purified recombinant Her-NLS fusion protein binds plasmid DNA and specifically transfects MDA-MB-453 cells overexpressing the epidermal growth factor receptors HER2/3 in vitro. The approach described would also permit replacement of heregulin ligand with other targeting moieties that would be suited to cell-specific nucleic acid delivery mediated via receptor-ligand interactions.Keywords: cell targeting, nucleic acid delivery, nuclear localization sequences, heregulin, transfection, HER2 receptors |
format |
article |
author |
Sivakumar Jeyarajan Jennifer Xavier N Madhusudhana Rao et al |
author_facet |
Sivakumar Jeyarajan Jennifer Xavier N Madhusudhana Rao et al |
author_sort |
Sivakumar Jeyarajan |
title |
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
title_short |
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
title_full |
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
title_fullStr |
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
title_full_unstemmed |
Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein |
title_sort |
plasmid dna delivery into mda-mb-453 cells mediated by recombinant her-nls fusion protein |
publisher |
Dove Medical Press |
publishDate |
2010 |
url |
https://doaj.org/article/d10649d76b1944679790f21da2675c95 |
work_keys_str_mv |
AT sivakumarjeyarajan plasmiddnadeliveryintomdamb453cellsmediatedbyrecombinanthernlsfusionprotein AT jenniferxavier plasmiddnadeliveryintomdamb453cellsmediatedbyrecombinanthernlsfusionprotein AT nmadhusudhanarao plasmiddnadeliveryintomdamb453cellsmediatedbyrecombinanthernlsfusionprotein AT etal plasmiddnadeliveryintomdamb453cellsmediatedbyrecombinanthernlsfusionprotein |
_version_ |
1718400499577782272 |